aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.2880
-0.0061 (-2.07%)
Oct 2, 2026, 11:59 AM EDT - Market open
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $28.25 million as of October 2, 2026. Its market cap has decreased by -63.74% in one year.
Market Cap
28.25M
Enterprise Value
-17.87M
1-Year Change
-63.74%
Ranking
Category
Stock Price
$0.29
ChartMarket Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $28.25M, a decrease of -91.62%. That is a compound annual growth rate of -19.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 29.70M | -61.28% |
| Dec 31, 2025 | 76.70M | -74.76% |
| Dec 31, 2024 | 303.90M | 267.92% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
| May 7, 2015 | 337.10M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 31.62M |
| LeonaBio | 31.47M |
| Quantum BioPharma | 31.16M |
| CEL-SCI | 30.78M |
| NanoViricides | 30.64M |
| Karyopharm Therapeutics | 29.49M |
| Context Therapeutics | 29.38M |
| IGC Pharma | 29.01M |